Chen S-H, Hsiao S-Y, Chang K-Y, Chang J-Y. New insights into oral squamous cell carcinoma: From clinical aspects to molecular tumorigenesis. Int J Mol Sci. 2021;22:2252.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almangush A, Leivo I, Mäkitie AA. Biomarkers for immunotherapy of oral squamous cell carcinoma: Current status and challenges. Front Oncol. 2021;11: 616629.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15:44.

Article  PubMed  PubMed Central  Google Scholar 

Yu J, Fu L, Wu R, Che L, Liu G, Ran Q, et al. Immunocytes in the tumor microenvironment: recent updates and interconnections. Front Immunol. 2025;16:1517959.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Dong X, Li B. Tumor microenvironment in oral squamous cell carcinoma. Front Immunol. 2024;15:1485174.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi S-W, Kim JH, Hong J, Kwon M. Mapping immunotherapy potential: spatial transcriptomics in the unraveling of tumor-immune microenvironments in head and neck squamous cell carcinoma. Front Immunol. 2025;16:1568590.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohan SP, Bhaskaran MK, George AL, Thirutheri A, Somasundaran M, Pavithran A. Immunotherapy in oral cancer. J Pharm Bioallied Sci. 2019;11:S107-11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iraji D, Oftedal BE, Wolff ASB. Th17 cells: Orchestrators of mucosal inflammation and potential therapeutic targets. Crit Rev Immunol. 2023;43:25–52.

Article  PubMed  Google Scholar 

Kurebayashi Y, Nagai S, Ikejiri A, Koyasu S. Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells. Genes Cells. 2013;18:247–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Capone A, Naro C, Bianco M, De Bardi M, Noël F, Macchi P, et al. Systems analysis of human T helper17 cell differentiation uncovers distinct time-regulated transcriptional modules. iScience. 2021;24:102492.

Kim HS, Jang SW, Lee W, Kim K, Sohn H, Hwang SS, et al. PTEN drives Th17 cell differentiation by preventing IL-2 production. J Exp Med. 2017;214:3381–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Intosalmi J, Ahlfors H, Rautio S, Mannerstöm H, Chen ZJ, Lahesmaa R, et al. Analyzing Th17 cell differentiation dynamics using a novel integrative modeling framework for time-course RNA sequencing data. BMC Syst Biol. 2015;9:81.

Article  PubMed  PubMed Central  Google Scholar 

Lücke J, Shiri AM, Zhang T, Kempski J, Giannou AD, Huber S. Rationalizing heptadecaphobia: TH 17 cells and associated cytokines in cancer and metastasis. FEBS J. 2021;288:6942–71.

Article  PubMed  Google Scholar 

Anvar MT, Rashidan K, Arsam N, Rasouli-Saravani A, Yadegari H, Ahmadi A, et al. Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies? Cancer Cell Int. 2024;24:355.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan Y, Yang W, Tang B, Wang X, Zhang Q, Li W, et al. The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment. Front Immunol. 2023;14:1192303.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alizadeh D, Katsanis E, Larmonier N. The multifaceted role of Th17 lymphocytes and their associated cytokines in cancer. Clin Dev Immunol. 2013;2013: 957878.

Article  PubMed  PubMed Central  Google Scholar 

Bailey SR, Nelson MH, Himes RA, Li Z, Mehrotra S, Paulos CM. Th17 cells in cancer: the ultimate identity crisis. Front Immunol. 2014;5:276.

Article  PubMed  PubMed Central  Google Scholar 

Wacleche VS, Landay A, Routy J-P, Ancuta P. The Th17 lineage: From barrier surfaces homeostasis to autoimmunity, cancer, and HIV-1 pathogenesis. Viruses. 2017;9:303.

Article  PubMed  PubMed Central  Google Scholar 

Fabre J, Giustiniani J, Garbar C, Antonicelli F, Merrouche Y, Bensussan A, et al. Targeting the tumor microenvironment: The protumor effects of IL-17 related to cancer type. Int J Mol Sci. 2016;17:1433.

Article  PubMed  PubMed Central  Google Scholar 

Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med. 2009;206:1457–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng W-Q, Zhang Y-C, Xu Z-Q, Yu S-Y, Huo J-T, Tuersun A, et al. IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8 + T-cell tumour infiltration. J Transl Med. 2023;21:335.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santegoets SJ, Turksma AW, Powell DJ Jr, Hooijberg E, de Gruijl TD. IL-21 in cancer immunotherapy: At the right place at the right time. Oncoimmunology. 2013;2:e24522.

Article  PubMed  PubMed Central  Google Scholar 

De Simone V, Pallone F, Monteleone G, Stolfi C. Role of TH17 cytokines in the control of colorectal cancer. Oncoimmunology. 2013;2:e26617.

Article  PubMed  PubMed Central  Google Scholar 

Ladjevac N, Milovanovic M, Jevtovic A, Arsenijevic D, Stojanovic B, Dimitrijevic Stojanovic M, et al. The role of IL-17 in the pathogenesis of oral squamous cell carcinoma. Int J Mol Sci. 2023;24:9874.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marques HS, de Brito BB, da Silva FAF, Santos MLC, de Souza JCB, Correia TML, et al. Relationship between Th17 immune response and cancer. World J Clin Oncol. 2021;12:845–67.

Article  PubMed  PubMed Central  Google Scholar 

Wang L, Zhang Y, Xie F. T-regulatory cell/T helper 17 cell imbalance functions as prognostic biomarker of oral squamous cell carcinoma - CONSORT. Medicine (Baltimore). 2020;99:e23145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guéry L, Hugues S. Th17 cell plasticity and functions in cancer immunity. Biomed Res Int. 2015;2015: 314620.

Article  PubMed  PubMed Central  Google Scholar 

Gaafar NM, Osman TA-H, Ahmed IA, Elsheikh M, Dongre H, Jacobsen MR, et al. Characterization of immune cell infiltrate in tumor stroma and epithelial compartments in oral squamous cell carcinomas of Sudanese patients. Clin Exp Dent Res. 2022;8:130–40.

Yu Q, Lou X-M, He Y. Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway. PLoS One. 2015;10:e0120855.

Article  PubMed  PubMed Central  Google Scholar 

Jiang L, Ma Z, Song L, Zhu C, Li J, Su Z, et al. Expression of interleukin-17 in oral tongue squamous cell carcinoma and its effect on biological behavior. Sci Rep. 2025;15:3195.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greten TF, Zhao F, Gamrekelashvili J, Korangy F. Human Th17 cells in patients with cancer: Friends or foe?: Friends or foe? Oncoimmunology. 2012;1:1438–9.

Article  PubMed  PubMed Central